Q3 2022 Catalyst Pharmaceuticals Inc Earnings Call Transcript
Good day, ladies and gentlemen and welcome to the Catalyst Pharmaceutical Incorporated Third Quarter 2022 Financial Results conference call. (Operator Instructions)
At this time, it is my pleasure to turn the floor over to your host, Ali Grande, Chief Financial Officer. Ma'am, the floor is yours.
Good morning, everyone, and thank you for joining our conference call to discuss Catalysts Third Quarter 2022 Financial Results and Corporate Highlights. Leading the call today is Patrick McEnany, Chairman and Chief Executive Officer. We are also joined by Dr. Steven Miller, our Chief Operating Officer and Chief Scientific Officer and Jeffrey Del Carmen, our Chief Commercial Officer. Further, for the Q&A session, we will also have Dr. Gary Ingenito, our Chief Medical and Regulatory Officer.
Before we begin, I would like to remind you that in the following comments and in the Q&A session, we will make statements about expected future results, which may be forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |